Skip to main content

Peer Review reports

From: No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

Original Submission
26 Sep 2009 Submitted Original manuscript
9 Nov 2009 Reviewed Reviewer Report - Jose Agundez
11 Nov 2009 Reviewed Reviewer Report - Magnus Ingelman-Sundberg
19 Jan 2010 Author responded Author comments - Annette Vangsted
Resubmission - Version 2
19 Jan 2010 Submitted Manuscript version 2
4 Feb 2010 Reviewed Reviewer Report - Jose Agundez
22 Mar 2010 Reviewed Reviewer Report - Magnus Ingelman-Sundberg
30 Apr 2010 Reviewed Reviewer Report - Kui Zhang
Resubmission - Version 3
Submitted Manuscript version 3
14 Jun 2010 Author responded Author comments - Annette Vangsted
Resubmission - Version 4
14 Jun 2010 Submitted Manuscript version 4
25 Jun 2010 Reviewed Reviewer Report - Kui Zhang
25 Jul 2010 Author responded Author comments - Annette Vangsted
Resubmission - Version 5
25 Jul 2010 Submitted Manuscript version 5
Publishing
4 Aug 2010 Editorially accepted
4 Aug 2010 Article published 10.1186/1471-2407-10-404

You can find further information about peer review here.

Back to article page